New targets for obesity pharmacotherapy. Review uri icon

Overview

abstract

  • An understanding of the mechanisms that regulate energy homeostasis is essential for understanding novel obesity therapies. The status of energy reserves is communicated to the brain by adiposity and satiety signals. These signals modify either anabolic or catabolic pathways and, consequently, alter food intake in line with signaled energy requirements. New antiobesity therapies are in development that target anabolic or catabolic regulatory networks to reduce food intake and/or increase energy expenditure to promote weight loss.

publication date

  • May 1, 2007

Research

keywords

  • Anti-Obesity Agents
  • Obesity

Identity

Scopus Document Identifier

  • 34247181123

Digital Object Identifier (DOI)

  • 10.1038/sj.clpt.6100163

PubMed ID

  • 17438540

Additional Document Info

volume

  • 81

issue

  • 5